Home » Stocks » Accuray

Accuray Incorporated (ARAY)

Stock Price: $3.10 USD -0.03 (-0.96%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 282.72M
Revenue (ttm) 382.93M
Net Income (ttm) 3.83M
Shares Out 91.20M
EPS (ttm) 0.04
PE Ratio 77.50
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $3.10
Previous Close $3.13
Change ($) -0.03
Change (%) -0.96%
Day's Open 3.10
Day's Range 3.08 - 3.14
Day's Volume 445,888
52-Week Range 1.33 - 4.68

More Stats

Market Cap 282.72M
Enterprise Value 394.52M
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 91.20M
Float 87.05M
EPS (basic) 0.04
EPS (diluted) 0.04
FCF / Share -0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.29%
FCF Yield n/a
Payout Ratio n/a
Shares Short 4.35M
Short Ratio 5.88
Short % of Float 4.99%
Beta 2.03
PE Ratio 77.50
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.74
PB Ratio 4.44
Revenue 382.93M
Operating Income 12.54M
Net Income 3.83M
Free Cash Flow -5.03M
Net Cash -111.79M
Net Cash / Share -1.23
Gross Margin 39.10%
Operating Margin 3.27%
Profit Margin 1.00%
FCF Margin -1.31%
ROA 1.69%
ROE 6.74%
ROIC 1.60%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(125.81% upside)
Current: $3.10
Target: 7.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-8.56%3.43%5.6%-3.86%5%2.81%16.91%-22.79%84.1%-
Gross Profit15016316214115914514397.64137107
Operating Income12.540.58-3.80-9.82-4.87-19.17-18.14-92.86-56.23-27.83
Net Income3.83-16.43-23.90-29.58-25.50-40.21-35.45-103-72.04-26.68
Shares Outstanding89.8787.4784.8982.5080.5178.2875.8073.2870.8960.09
Earnings Per Share0.04-0.19-0.28-0.36-0.32-0.51-0.47-1.41-1.02-0.44
Operating Cash Flow-1.47-29.6418.33-0.3830.93-14.410.35-66.18-38.2812.40
Capital Expenditures-3.56-4.31-6.28-5.03-8.07-10.45-11.93-15.13-10.77-4.02
Free Cash Flow-5.03-33.9512.06-5.4122.86-24.85-11.59-81.30-49.058.38
Cash & Equivalents11088.1893.5310916914817317714599.08
Total Debt22216013116521020019619979.47-
Net Cash / Debt-112-71.67-37.54-55.43-41.04-52.06-22.22-21.6465.6099.08
Book Value63.6449.8748.6346.5359.6675.7898.55107196230
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Accuray Incorporated
Country United States
Employees 932
CEO Joshua H. Levine

Stock Information

Ticker Symbol ARAY
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: ARAY
IPO Date February 8, 2007


Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.